---
$id: https://graph.org.ai/products/commodity/51172117
$type: Product
source: UNSPSC
code: "51172117"
title: "Aseripide"
class: "51172100"
classTitle: "Antispasmodics"
family: "51170000"
familyTitle: "Drugs affecting the gastrointestinal system"
segment: "51000000"
segmentTitle: "Pharmaceutical Products incl. Contraceptives and Vaccines"


---

# Aseripide

**UNSPSC Code**: 51172117
**Class**: [Antispasmodics](Antispasmodics.mdx)
**Family**: [Drugs affecting the gastrointestinal system](../Drugs affecting the gastrointestinal system.mdx)
**Segment**: [Pharmaceutical Products incl. Contraceptives and Vaccines](../../Pharmaceutical Products incl. Contraceptives and Vaccines.mdx)

This classification denotes an antispasmotic agent with the molecular formula C26H30FN3O6S, a preparation that US FDA regulates as an active ingredient or moiety under Unique Ingredient Identifier G2M24F1I2A, chemically known as (2r,4r)-3-(n-((3-((s)-1-carboxyethyl)phenyl)carbamoyl)glycyl)-2-(o-fluorophenyl)-4-thiazolidinecarboxylic acid, 4-tert-butylester but generally known as aseripide, which bears US NIH Compound Identifier 179339. European Medicines Agency schedules Aseripide in its eXtended EudraVigilance Medicinal Product Dictionary or XEVMPD under Index SUB05580MIG. The term ASERIPIDE is an International Non-Proprietary Name. Most nations schedule aseripide under HS 29341000 and SITC 51579. As of Q4 2014, ASERIPIDE remains the US FDA Preferred Term for this commodity. Aseripide bears US NLM identifiers UMLS ID C2346860 and NCI Concept Code C73172. SMILES: S1CC(N(C1C1C(F)CCCC1)C(=O)CNC(=O)NC1CC(C(C)C(=O)O)CCC1)(C(C)(C)C)C(=O)O.

